Leveraging the activity of tumor vaccines with cytotoxic chemotherapy

Leisha A. Emens, Elizabeth M. Jaffee

Research output: Contribution to journalReview articlepeer-review

Abstract

Engaging the power of the patient's own immune system to actively seek out and destroy transformed cells holds great promise for cancer therapy. Tumor vaccines offer the potential for preventing cancer in high-risk individuals, preventing disease relapse after diagnosis and initial therapy, and shifting the balance of the host-tumor interaction to mitigate the progression of advanced cancers. The therapeutic activity of tumor vaccines is limited by the sheer physical burden of the cancer itself, pathways of local immune tolerance and escape active within the tumor microenvironment, and superimposed potent systemic mechanisms of immune tolerance. In this review, we describe how cytotoxic chemotherapy can be integrated with tumor vaccines using unique doses and schedules to break down these barriers, releasing the full potential of the antitumor immune response to eradicate disease.

Original languageEnglish (US)
Pages (from-to)8059-8064
Number of pages6
JournalCancer Research
Volume65
Issue number18
DOIs
StatePublished - Sep 15 2005

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Leveraging the activity of tumor vaccines with cytotoxic chemotherapy'. Together they form a unique fingerprint.

Cite this